REDHILL BIOPHARMA LTD. Current Restricted Cash And Cash Equivalents
REDHILL BIOPHARMA LTD. (RDHL) had Current Restricted Cash And Cash Equivalents of $739.00 thousand as of 2024-06-30, per its 6-K filed 2024-08-29.
Financial Statements › Notes
ifrs-full:CurrentRestrictedCashAndCashEquivalents · last filed 2025-04-10
- 2024-06-30: Current Restricted Cash And Cash Equivalents $739.00K.
- 2023-12-31: Current Restricted Cash And Cash Equivalents $790.00K.
- 2023-06-30: Current Restricted Cash And Cash Equivalents $9.14M.
- 2022-12-31: Current Restricted Cash And Cash Equivalents $16.00M.
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2024-06-30 | $739.00K 6-K · filed 2024-08-29 |
| 2023-12-31 | $790.00K 20-F · filed 2025-04-10 |
| 2023-06-30 | $9.14M 6-K · filed 2023-08-17 |
| 2022-12-31 | $16.00M 20-F · filed 2024-04-08 |
| 2022-06-30 | $16.00M 6-K · filed 2022-11-07 |